Fulcrum Therapeutics, Inc. (FULC) Q1 2026 Earnings Call Transcript

Understand this faster with AI
SA Transcripts159.46K FollowersFollow5ShareSaveCommentsPlay Earnings CallPlay Earnings Call Fulcrum Therapeutics, Inc. (FULC) Q1 2026 Earnings Call April 27, 2026 8:00 AM EDT Company Participants Alexander Sapir - CEO, President & DirectorAlan Musso - Chief Financial OfficerIain Fraser - Senior Vice President of Early Development Conference Call Participants Joseph Schwartz - Leerink Partners LLC, Research DivisionAnupam Rama - JPMorgan Chase & Co, Research DivisionKristen Kluska - Cantor Fitzgerald & Co., Research DivisionCorinne Jenkins - Goldman Sachs Group, Inc., Research DivisionJames Condulis - Stifel, Nicolaus & Company, Incorporated, Research DivisionMatthew Biegler - Oppenheimer & Co. Inc., Research DivisionGregory Renza - Truist Securities, Inc., Research Division Presentation Operator Good morning, and welcome to Fulcrum Therapeutics First Quarter 2026 Financial Results and Business Update Conference Call. [Operator Instructions] This call is being webcast live and can be accessed on the Investors section of Fulcrum's website at www.fulcrumtx.com and is being recorded. Please be reminded that remarks during this call may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, may include statements about the company's future expectations and plans, clinical development time lines and financial projections. While these forward-looking statements represent Fulcrum's views as of today, they should not be relied upon as representing the company's views in the future. Fulcrum may update these statements in the future, but is not taking on an obligation to do so. Please refer to Fulcrum's most recent filings with the Securities and Exchange Commission for discussions of certain risks and uncertainties associated with the company's business. Leading the call today will be Alex Sapir, CEO and President of Fulcrum. Joining Alex on the call are Alan Musso, Chief Financial Officer; and Dr. Iain Fraser, Senior Vice President, Clinical Development. After providing updates on the company's key programs, there will be a brief Q&A in which the Fulcrum management team will be available for questions.
Tags
Source Information
Discussion
0 professional contributions
Sign in to join this professional discussion.
Be the first to add a constructive contribution.
